FEASIBILITY AND OUTCOME OF COMPLETE SECONDARY TUMOR RESECTION FOR PATIENTS WITH ADVANCED OVARIAN-CANCER

被引:11
作者
LAWTON, F
LUESLEY, D
REDMAN, C
CHAN, KK
VARMA, R
BLACKLEDGE, G
机构
[1] UNIV BIRMINGHAM,ACAD DEPT OBSTET & GYNECOL,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND
[2] UNIV BIRMINGHAM,CANC RES CAMPAIGN CLIN TRIALS UNIT,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND
[3] BIRMINGHAM & MIDLAND HOSP WOMEN,BIRMINGHAM B11 4HL,W MIDLANDS,ENGLAND
关键词
cis‐platinum; secondary cytoceductive surgery; surgical debulking;
D O I
10.1002/jso.2930450105
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
From November 1981 to July 1985, 124 women with International Federation of Gynecology and Obstetrics (FIGO) stage III ovarian cancer were treated in prospective studies of surgery and chemotherapy in our institution. Patients with no macroscopic cancer after primary surgery (n = 16) received five cycles of adjuvant cis‐platinum; those with residual cancer after primary laparotomy (n = 108) underwent a second surgical debulking after three or five cycles of cis‐platinum‐based cytoreductive chemotherapy. Total macroscopic tumor clearance was achieved in 26 of these 108 patients. Fourteen patients with total tumor excision at primary laparotomy remain in complete clinical remission a minimum of 36 months after diagnosis, but the median progression‐free interval for the other two groups was 9 and 17 months, respectively. The survival for women who have total tumor clearance only at secondary surgery after chemotherapy is inferior to that for women with primary macroscopic tumor excision followed by chemotherapy. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:14 / 19
页数:6
相关论文
共 17 条
[1]  
BEREK JS, 1983, OBSTET GYNECOL, V61, P189
[2]  
DAUPLAT J, 1986, CANCER, V57, P1627, DOI 10.1002/1097-0142(19860415)57:8<1627::AID-CNCR2820570831>3.0.CO
[3]  
2-D
[4]   THE TREATMENT OF ADVANCED OVARIAN-CARCINOMA .2. INTERVAL REASSESSMENT OPERATIONS DURING CHEMOTHERAPY [J].
HEINTZ, APM ;
VANOOSTEROM, AT ;
BAPTIST, J ;
TRIMBOS, MC ;
SCHABERG, A ;
VANDERVELDE, E ;
NOOY, M .
GYNECOLOGIC ONCOLOGY, 1988, 30 (03) :359-371
[5]   INFLUENCE OF SECONDARY CYTOREDUCTION AT THE TIME OF 2ND-LOOK LAPAROTOMY ON THE SURVIVAL OF PATIENTS WITH EPITHELIAL OVARIAN-CARCINOMA [J].
HOSKINS, WJ ;
RUBIN, SC ;
DULANEY, E ;
CHAPMAN, D ;
ALMADRONES, L ;
SAIGO, P ;
MARKMAN, M ;
HAKES, T ;
REICHMAN, B ;
JONES, WB ;
LEWIS, JL .
GYNECOLOGIC ONCOLOGY, 1989, 34 (03) :365-371
[6]   LONG-TERM SURVIVAL OF ADVANCED REFRACTORY OVARIAN-CARCINOMA PATIENTS WITH SMALL-VOLUME DISEASE TREATED WITH INTRAPERITONEAL CHEMOTHERAPY [J].
HOWELL, SB ;
ZIMM, S ;
MARKMAN, M ;
ABRAMSON, IS ;
CLEARY, S ;
LUCAS, WE ;
WEISS, RJ .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (10) :1607-1612
[7]  
JOYEUX H, 1986, CANCER-AM CANCER SOC, V57, P142, DOI 10.1002/1097-0142(19860101)57:1<142::AID-CNCR2820570129>3.0.CO
[8]  
2-#
[9]  
LAWTON FG, 1989, OBSTET GYNECOL, V73, P61
[10]  
LIPPMAN SM, 1988, CANCER, V61, P2571, DOI 10.1002/1097-0142(19880615)61:12<2571::AID-CNCR2820611231>3.0.CO